1. Home
  2. NLSP vs ULY Comparison

NLSP vs ULY Comparison

Compare NLSP & ULY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • ULY
  • Stock Information
  • Founded
  • NLSP 2015
  • ULY 2013
  • Country
  • NLSP Switzerland
  • ULY United States
  • Employees
  • NLSP N/A
  • ULY N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • ULY
  • Sector
  • NLSP Health Care
  • ULY
  • Exchange
  • NLSP Nasdaq
  • ULY Nasdaq
  • Market Cap
  • NLSP 5.9M
  • ULY 6.0M
  • IPO Year
  • NLSP 2021
  • ULY N/A
  • Fundamental
  • Price
  • NLSP $1.50
  • ULY $4.66
  • Analyst Decision
  • NLSP
  • ULY Strong Buy
  • Analyst Count
  • NLSP 0
  • ULY 1
  • Target Price
  • NLSP N/A
  • ULY $12.00
  • AVG Volume (30 Days)
  • NLSP 102.5K
  • ULY 23.8K
  • Earning Date
  • NLSP 05-14-2025
  • ULY 05-12-2025
  • Dividend Yield
  • NLSP N/A
  • ULY N/A
  • EPS Growth
  • NLSP N/A
  • ULY N/A
  • EPS
  • NLSP N/A
  • ULY N/A
  • Revenue
  • NLSP N/A
  • ULY $142,905,000.00
  • Revenue This Year
  • NLSP N/A
  • ULY N/A
  • Revenue Next Year
  • NLSP N/A
  • ULY $17.87
  • P/E Ratio
  • NLSP N/A
  • ULY N/A
  • Revenue Growth
  • NLSP N/A
  • ULY N/A
  • 52 Week Low
  • NLSP $1.30
  • ULY $2.99
  • 52 Week High
  • NLSP $18.40
  • ULY $32.04
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 49.86
  • ULY 47.91
  • Support Level
  • NLSP $1.38
  • ULY $4.42
  • Resistance Level
  • NLSP $1.53
  • ULY $5.10
  • Average True Range (ATR)
  • NLSP 0.09
  • ULY 0.38
  • MACD
  • NLSP 0.02
  • ULY 0.05
  • Stochastic Oscillator
  • NLSP 64.91
  • ULY 60.49

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About ULY Urgent.ly Inc.

Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.

Share on Social Networks: